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Reference has been made in a previous paper (1) to the work of several authors 
(Swift,  Frei, Sulzberger,  Mu) on sensitization to arsphenamine and neoarsphen- 
amine.  In most of the  communications skin lesions  or "flare ups" at the  site 
of old injections were described.  Of 19 animals given intraperitoneal or intra- 
venous  injections  of  neutralized  arsphenamine  mixed  with  guinea  pig  serum 
Swift (2) observed, on reinjection of a similar mixture, "symptoms like those seen 
in anaphylaxis;" one animal succumbed in 10 minutes, and two others after some 
hours.  Arsphenamine alone,  without serum, did  not seem to  sensitize.  Kone 
and  Rothermund  (3)  after  unsuccessful  attempts  obtained  positive results  by 
sensitizing  with very small quantities of neosalvarsan and observed acute death 
with symptoms which  had '% certain similarity to anaphylactic shock" (trans- 
lated).  These experiments, briefly mentioned in  a  discussion  on allergy, have 
not, to our knowledge,  been published in detail. 
Lauf  (4)  injected  neosalvarsan solutions without  serum subcutaneously and 
upon intravenous reinjection observed severe anaphylactic symptoms in perhaps 
15 per cent of the animals and in others slight symptoms, but in no instance did 
death occur in anaphylactic shock.  The most striking results were obtained after 
a rest period of 6 months. 
Working with the guinea pig uterus (Schulz-Dale  method)Kall6s and Kall6s- 
Definer (5) found that reactions occurred in 7 of 11 cases after previous subcu- 
taneous treatment with horse serum-arsphenamine mixtures.  For the tests, also, 
serum mixtures were used.  Anaphylactic experiments other than those with the 
Schulz-Dale method are not mentioned.  According  to the authors, sensitization 
could be transferred passively. 
Birnbaum  (1934),  who  gives a  comprehensive review of  the  literature  (6), 
concludes  that there is no proof for the assumption that skin manifestations in 
human beings following administration of arsphenamine are true allergic  effects, 
and casts doubt on the reports concerning passive transfer of arsphenamine hyper- 
sensitiveness.  With regard to animal experiments he remarks that "it has never 
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been possible, even with large doses of arsphenamine,..,  to produce anaphylactic 
shock"  (translated). 
On account of the irregularity of effects, as recorded in the literature, 
and the differences between results of various investigators, attempts 
directed toward improving the technique were thought to be desirable. 
We found that, with a suitable method, intense local hypersensitive- 
TABLE  I* 
Sensitization effects  in two batches of guinea pigs similarly treated with one 
intracutaneous injection of 0.15 rag. arsphenamine, not neutralized, and neo- 
arsphenamine, respectively, in 0.1 cc. saline; tested after an interval of 1 month 
with the respective substances. 
No.  Animals sensitized to and reinjected 
with arsphenamine 
22, p.p.-p., el., necr.c. 4 
12, p., el., necr.c. 3 
9, p., el., necr.c. 3 
26, p., swol., neer.c. 3 
18, p., el., necr.c. 3 
19, p.p., el., necr.c. 3 
No.  Animals sensitized to and reinjected 
with neoarsphenamine 
13 
14 
15 
16 
17 
18 
5, p.p., sl.el. 
5, f.p., sl.el. 
4, a.cls., sl.el. 
a.neg. 
5, f.p., el. 
6, p., el. 
N'o.' 
-7- 
8 
9 
10 
11 
12 
No. 
19 
20 
21 
22 
23 
24 
Controls 
6, p.p., el. 
6, p.p., el. 
7, f.p., sl.el. 
5, p.p., el. 
5, f.p., el. 
5, f.p., el. 
Controls 
6, f.p., el. 
6, a.cls., ft. 
5, f.p., el. 
4, f.p., sl.el. 
6, p.p., sl.el. 
6, p.p., sl.eL 
* The following abbreviations are used: almost colorless (a.cls.), faintly pink 
(f.p.),  pale  pink  (p.p.), pink  (p.).  Other  designations are: almost  negative 
(a.neg.), flat (ft.), slightly elevated (sl.el.), elevated (el.), necrotic center (necr.c.). 
The figures give  diameters  of the  lesions in millimeters. 
ness could regularly be obtained  (1).  With arsphenamine solutions, 
not neutralized,  practically all  sensitized  animals gave  conspicuous 
lesions consisting of rather large pink elevated areas almost regularly 
with  central  necrosis.  When  compared  with  effects  produced  by 
neoarsphenamine,  it  appeared  that  arsphenamine  had  a  distinctly 
greater  sensitizing  capacity.  This  is  evidenced by  the  experiment 
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Strongly positive skin reactions to arsphenamine  were observed in 
seven experiments with more than 50 animals which in part are shown 
in Table II.  On the first injection only faint to pale pink lesions were 
produced, with a diameter of 4-7 mm. 
These observations prompted  attempts  to produce anaphylaxis  in 
animals sensitized by this method.  Preliminary experiments indicated 
that  several  injections  extending  over  a  rather  long  period  were 
effective; the technique developed was as follows. 
Guinea pigs were given 2 intracutaneous injections of 0.15 nag. arsphenamine, 
not neutralized, in 0.1 cc. saline a month apart and 3 weeks later injected intra- 
venously with a solution of 10 mg. arsphenamine in 0.1 cc. saline and 0.09 cc. 
N/1 NaOH, made up to 1.0 cc. with normal guinea pig serum.  In those animals 
which did not succumb to the first intravenous injection the dose was repeated 
after 3 weeks. 
The results obtained with three batches of guinea pigs treated with 
the same brand of arsphenamine and by the same method, are given in 
Table II. 
About half of the animals died in typical anaphylaxis on either the 
first  or  second injection,  while  still  others  presented  distinct  symp- 
toms.  It may be of interest to note that  the number of guinea pigs 
with no or very slight  symptoms, or those which died in  shock, was 
greater  than  the  number  of animals  showing  symptoms of medium 
degree. 
Of 50 controls injected intravenously in the same way as the animals 
previously treated, 35 showed no symptoms at all, 13 gave coughs, and 
2 were slightly sick.  The following drops in temperature of 0.5°C. or 
more were shown by one animal  each:  -0.5 ° ,  -0.6  ° ,  -0.7 ° ,  -1.2 ° , 
and  -  1.4  °. 
When,  in  another  batch of sensitized  animals,  instead of a  guinea 
pig serum-arsphenamine  mixture 5 mg. of arsphenamine,  not neutral- 
ized,  was  injected  intravenously  again  some  of  the  animals  suc- 
cumbed with anaphylactic symptoms, seeming to indicate that serum 
admixture  is not  necessary for the  success of the experiment  (Table 
III).  Whether  it offers  a  distinct  advantage  remains  to  be inves- 
tigated  in more extensive  experiments. 
In all, of 56 treated guinea pigs, 30 died in typical anaphylaxis, and a 
number  of  others  showed  distinct  symptoms,  whereas,  as  already 720  SENSITIZATION  WITH  CHEMICAL  COMPOUNDS.  III 
indicated, none of the 50 controls injected in the same manner as the 
treated guinea pigs died or developed severe symptoms. 
TABLE  II 
Combined table.  Sensitization with arsphenamine (Winthrop  Chemical Com- 
pany).  The second column gives the diameter of the skin lesions in millimeters. 
Figures in parentheses  indicate change in temperature  (°C.). 
No. 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
4O 
41 
42 
43 
44 
45 
46 
47 
48 
49 
Second 
intracu- 
taneous 
injection 
22 
22 
14 
17 
23 
18 
16 
7 
14 
21 
20 
22 
10 
25 
21 
15 
25 
9 
17 
27 
7 
18 
17 
21 
20 
First intravenous  injection 
Symptoms 
None ('0.1) 
"  (-0.9) 
Slight (- 1.9) 
,'  (-t.o) 
t 19 rain. 
Slight (- 1.1) 
None (-0.4) 
"  (o) 
Slight (- 2.7) 
"  (-t  s) 
$ 6 rain. 
t3  " 
Moderate (-- 1.6) 
t 20 rain. 
Moderate  (-- 1.0) 
t5 rain. 
t7  " 
t4  " 
Slight (0) 
t 38 rain. 
None (+ O. 1) 
"  (0) 
t  19 rain. 
None (0) 
t4 rain. 
Second intravenous injection 
Symptoms 
None (0) 
"  (-0.s) 
t7 rain. 
t8  " 
Slight (-O.S) 
t 8 rain. 
Moderate (+0.2) 
Severe (--3.7) 
None 
Slight (0) 
None (+0.2) 
t Overnight 
None (0) 
"  (0) 
None (+0.2) 
t Designates death.  Animals dying in a short time all showed the typical pic- 
ture (lungs inflated, heart beating) on autopsy. 
In a similar experiment with 5 animals an arsphenamine preparation,  procured 
from the Abbott Laboratories, was used.  In this lot 2 animals died on the sec- 
ond intravenous injection. 
A  point of special significance is that in the experiments reported  a 
synthetic chemical substance, without being used in chemical combina- 
tion with protein,  produces skin  sensitization  as well  as the  anaphy- K.  LANDSTEINER  AND  JOHN  JACOBS  721 
lactic state.  It will be of interest to follow up the mechanism of this 
sensitization. 
TABLE  HI 
Sensitization effects in a batch of guinea pigs treated~with two skin injections a 
month  apart  of  0.15  rag.  arsphenamine,  not  neutralized,  (Winthrop  Chemical 
Company)  and  3  weeks after  the  second  injection,  injected  intravenously  with 
5.0 mg. of the same preparation in 1.0 cc. saline.  The second, similar intravenous 
injection was given 3 weeks after the first.  Figures in parentheses indicate change 
in temperature  (°C.). 
No. 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
First intravenous injection 
Symptoms 
Slight (--3.S) 
None (0) 
"  (-0.1) 
t  8 rain. 
Snght (-2. S) 
Moderate (--4.4) 
None (0) 
Controls 
None C-0.1) 
"  (+o.1) 
"  (+o.2) 
"  (+0.1) 
"  (-o.1) 
"  (o) 
"  CO) 
No. 
64 
65 
66 
67 
68 
69 
70 
Second intravenous injection 
Symptoms 
None (0) 
Moderate (-- 1.0) 
Coughs (0) 
t 16 rain. 
t sl  ', 
Coughs (+0.1) 
Controls 
None (0) 
"  (+o.2) 
"  (+o.  1) 
"  (0) 
"  CO) 
"  (+0.1) 
"  (o) 
SUMMARY 
Experiments are described which show that with a given treatment 
guinea pigs can be sensitized to arsphenamine, so that a  considerable 
percentage die in anaphylactic shock on intravenous administration 
of the substance. 
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